RENEWAL is designed to offer hope and comfort to people suffering from mental health disorders or addiction disorders, and support to the people who love them. Our approach is based on respect for the dignity of the people we serve and the belief that through a faith-based program, life-changing results are possible.

RENEWAL: Christian Treatment and Recovery is an optional treatment supplement available through Brookhaven Hospital in Tulsa, Oklahoma. At Brookhaven, we understand that when you are suffering from an eating disorder, a personality disorder, a behavioral health disorder or chemical dependency, life can seem utterly hopeless. It can cause Christians to feel abandoned and distant from God. However, by strengthening your spirituality, in conjunction with our professional medical services, you can experience results that you never thought were possible.

RENEWAL is based on the belief in:

God who created us and loves us (Genesis 1:26)
Jesus Christ who redeems us (Isaiah 53:5)
The Holy Spirit who guides us (Acts 1:8)

When you participate in RENEWAL, you’re part of something much bigger than yourself. Brookhaven clients receive expert care from our team of mental professionals. Treatment is solution-focused and success-oriented. Our goal is to minimize symptoms, help individuals address life problems and live fulfilling lives. Sometimes healing requires a helping hand. We’re here to provide the guidance and support you need to recover.

Christian Care
The RENEWAL program at Brookhaven Hospital incorporates your faith into the recovery process in order to address your physical, mental and spiritual needs

Christian Drug Rehab
Our program provides a nurturing atmosphere that allows you to sober up and strengthen your bond with God.

Christian Bulimia Treatment
Individuals with bulimia alternate between compulsive binge eating and purging. Without treatment bulimia can be deadly. Brookhaven’s RENEWAL program can offer medical, psychological and faith-based eating disorder treatments.

PTSD Treatment
Post-traumatic stress disorder (PTSD) occurs after a traumatic event. Without getting proper help it can be debilitating. Strengthening your faith can help you confront the past and form a brighter future.

Christian Healing
When you are part of the RENEWAL program, you are part of something bigger than yourself. You are part of a support system based on professional medical care as well as spiritual guidance.

Compulsive Overeating
When you suffer from compulsive overeating disorder, your meals and your life can seem out of control. Take a faith-based approach to your eating disorder treatment at RENEWAL.

Anorexia Treatment
Anorexia is characterized by the restriction of food intake and the refusal to maintain a healthy body weight. Without getting help, anorexia can be life-threatening.

Bipolar Disorder Treatment
Everyone experiences ups and downs, but when you’re suffering from bipolar disorder life can seem out of control. Brookhaven’s RENEWAL program incorporates your spirituality into an advanced behavioral health program.

OCD Treatment
Obsessive-compulsive disorder (OCD) can fill your life with uncontrollable thoughts (obsessions) and rituals (compulsions) and stand in the way of relationships and your career.

Risks of Suicidal Ideation and Behavior with Epilepsy Drugs Reaffirmed


The FDA released the results of an analysis of 11 anticonvulsant drugs used primarily for seizures and certain psychiatric conditions in January, which found double the risk of suicidality associated with the drugs. Accordingly, the FDA voted that risks be described in a medication guide that patients taking the drugs would be provided. The FDA has yet to issue a black box warning due to concerns that such a warning would prevent physicians from prescribing such drugs to those that need them. However, Russell Katz, M.D., director of neurology products for the FDA’s Center for Drug Evaluation and Research, said that the FDA may still issue a black box warning. The following is an excerpt of an article from Medpage Today that discusses the FDA’s findings:

The drugs evaluated were carbamazepine (Carbatrol, Equetro, Tegretol, Tegretol XR), felbamate (Felbatol), gabapentin (Neurontin), lamotrigine (Lamictal), levetiracetam (Keppra), oxcarbazepine (Trileptal), pregabalin (Lyrica), tiagabine (Gabitril), topiramate (Topamax), divalproex sodium (Depakote), and zonisamide (Zonegran).

A meta-analysis of 199 placebo-controlled trials consisting of 27,863 patients on active treatment and 16,029 on placebo found that 0.37% of those receiving one of the 11 drugs and 0.22% of those taking placebo had suicidal ideation or behavior (OR 1.80, 95% CI 1.24 to 2.66).

For three of the drugs, there was no increased risk for suicidality — carbamazepine (OR 0.66), felbamate (OR not defined), divalproex (OR 0.91). The elevated risk only reached nominal significance for two of the other eight.

Dr. Katz explained why the agency and the committees concluded that the warnings should be applied to all epilepsy drugs.

The committee members “felt that the signal occurred across a whole range of drugs with different mechanisms of action,” he said, “so it’s perfectly reasonable to conclude that the other drugs that weren’t studied were likely to show the same signal.”

Click here to read the rest of this article from Medpage Today

No comments yet.

Leave a Reply